Basal MMP2 mRNA was elevated in PAH-hPASMCs and further increased by serotonin; these effects were 5-HT1BR- and Nox1-dependent, through the use of pharmacological inhibitors, SB224289 and ML171, respectively (Figure 4C). The gene discussed is MMP2; the disease is pulmonary arterial hypertension.